IL-4 in lymphoma: does the target matter?

Journal article

Peer reviewed

Leukemia & lymphoma, Vol.48(7), pp.1261-1263

2007-07

PMID: 17613751

Abstract

Treatment Outcome

Interleukin-4 - pharmacology

Signal Transduction - drug effects

Interleukin-4 - therapeutic use

Humans

Lymphoma, Non-Hodgkin - drug therapy

8 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.6 Immunology; 1.6.452 Somatic Hypermutation
Web Of Science research areas: Hematology; Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: IL-4 in lymphoma: does the target matter?
Creators: Izidore S Lossos - Division of Hematology-Oncology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, FL 33136, USA. ilossos@med.miami.edu
Publication Details: Leukemia & lymphoma, Vol.48(7), pp.1261-1263
Publisher: United States
Grant note: R01 CA109335 / NCI NIH HHS
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 17613751
Record Identifier: 991031561210202976